The Microbiome's Unique Role in Soft Tissue Sarcoma Froelich, Warren Froelich, Warren Less Oncology Times. 45(6):1,7, March 20, 2023. Favorite PDF Permissions Free
Risk Factors for Thoracic Soft Tissue Sarcomas in Breast Cancer Survivors Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 45(2):1,9,12, January 20, 2023. Favorite PDF Permissions Free
Hypofractionated Radiation for Sarcoma Shown As Safe & Effective Holt, Chuck Holt, Chuck Less Oncology Times. 45(1):20, January 5, 2023. Favorite PDF Permissions Free
The rEECur Trial Highlights Therapies for Refractory Ewing Sarcoma Froelich, Warren Froelich, Warren Less Oncology Times. 44(14):23, July 20, 2022. Favorite PDF Permissions Free
Sirolimus Protein-Bound Particles (Fyarro™) Mann, Janelle E. Mann, Janelle E. Less Oncology Times. 44(14):13,19, July 20, 2022. Favorite PDF Permissions Free
Spotlight on Cardiac Angiosarcoma: A Review of This Rare Disease Galamba, Elizabeth Rose Galamba, Elizabeth Rose Less Oncology Times. 44(5):22, March 5, 2022. Favorite PDF Permissions Free
Control of Rhabdomyosarcoma Cell Identity Provides Treatment Clues Less Oncology Times. 43(19):32, October 5, 2021. Favorite PDF Permissions Free
New Guideline on Radiation Therapy for Soft Tissue Sarcoma in Adults Less Oncology Times. 43(16):21, August 20, 2021. Favorite PDF Permissions Free
Genetic Testing Options for Children With Rhabdomyosarcoma Less Oncology Times. 43(15):23, August 5, 2021. Favorite PDF Permissions Free
The Evolving Role of Radiation Therapy in Adult Soft Tissue Sarcoma Kumar Das, Dibash Kumar Das, Dibash Less Oncology Times. 43(11):38,53, June 5, 2021. Favorite PDF Permissions Free
Genomic Sequencing Initiative Advances Angiosarcoma Research Holt, Chuck Holt, Chuck Less Oncology Times. 42(11):19-20, June 5, 2020. Favorite PDF Permissions Free CME Test
Benefits of Selumetinib in NF1-Associated Plexiform Neurofibromas Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(24):34, December 20, 2019. Favorite PDF Permissions Free
Advancing Synovial Sarcoma Treatment With ADP-A2M4 Van Tine, Brian Van Tine, Brian Less Oncology Times. 41(24):1,4, December 20, 2019. Favorite PDF Permissions Free
Hafnium Nanoparticles & Sarcoma Response to Radiotherapy Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(12):36, June 20, 2019. Favorite PDF Permissions Free
An Update in the Management of Retroperitoneal Soft Tissue Sarcoma Villano, Anthony M.; Maselli, Kathryn M.; Levy, Angela D.; More Villano, Anthony M.; Maselli, Kathryn M.; Levy, Angela D.; Unger, Keith R.; Priebat, Dennis A.; Pollock, Raphael E.; Al-Refaie, Waddah B. Less Oncology Times. 40(8):17-19, April 20, 2018. Favorite PDF Permissions Free
Eribulin Improves Overall Survival for Liposarcoma, Leiomyosarcoma DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 38(9):30, May 10, 2016. Favorite PDF Permissions Free
PFS, Response Rate Found to Be Useful Surrogate Endpoints for RCTs DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 38(9):29, May 10, 2016. Favorite PDF Permissions Free
FDA Approves Halaven (Eribulin Mesylate) Injection for Liposarcoma Less Oncology Times. 38(5):39, March 10, 2016. Favorite PDF Permissions Free
FDA Approves Yondelis for Soft Tissue Sarcoma Subtypes Less Oncology Times. 37(22):20, November 25, 2015. Favorite PDF Permissions Free
Orphan Drug Status to Sarcoma Drug Less Oncology Times. 37(21):17, November 10, 2015. Favorite PDF Permissions Free
FDA Priority Review Status for Defibrotide and Halaven Less Oncology Times. 37(20):17, October 25, 2015. Favorite PDF Permissions Free
